Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry

John Cumbers, Contributor 5 February 2021

Synthetic biology company AbSci’s recent acquisition of the artificial intelligence platform, Denovium, could help get novel therapeutics to patients more quickly

Deploying machine learning to improve mental health

February 25, 2022, by Alison Gold | Danny Gross | Abdul Latif Jameel Clinic for Machine Learning in Health

A machine-learning expert and a psychology researcher/clinician may seem an unlikely duo. But MIT’s Rosalind Picard and ...

news & analysis

SDG 3. GOOD HEALTH & WELL-BEING BenevolentAI

BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies

October 14, 2021, by PR Newswire:

LONDON, Oct. 14, 2021 /PRNewswire/ — In a significant milestone for its (AI)-driven drug discovery platform, BenevolentAI ...

Pathway Raises $1.3 Million to Scale its AI-Powered Medical Knowledge Platform

October 14, 2021, by Business Wire Technology News

MONTREAL–(BUSINESS WIRE)–A solution to combat medical information overload, a major contributor to clinician burnout.

Read more on Business Wire Technology News

Comments are closed.

More in DRUG DISCOVERY

news & analysis

SDG 3. GOOD HEALTH & WELL-BEING DRUG DISCOVERY Engine Biosciences

Engine Biosciences expands its digital drug discovery pipeline with $43M round

May 27, 2021, by Devin Coldewey

Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. ...

news & analysis

SDG 3. GOOD HEALTH & WELL-BEING DRUG DISCOVERY Engine Biosciences

Engine Biosciences expands its digital drug discovery pipeline with $43M round

May 27, 2021, by Devin Coldewey

Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. ...

news & analysis

SDG 3. GOOD HEALTH & WELL-BEING DRUG DISCOVERY Cyclica

Interview with Naheed Kurji, Cofounder and CEO of Cyclica

May 12, 2021, by Caroline Lair

We cannot achieve the Sustainable Development Goals unless we end the ‘war on drugs’. Today we meet ...

Synthetic Biology Startup Acquires AI Platform To Disrupt The Drug Industry

This is how we lost control of our faces

The Rise of Responsible AI

Deploying machine learning to improve mental health

BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies

Pathway Raises $1.3 Million to Scale its AI-Powered Medical Knowledge Platform

More in DRUG DISCOVERY

Engine Biosciences expands its digital drug discovery pipeline with $43M round

Engine Biosciences expands its digital drug discovery pipeline with $43M round

Interview with Naheed Kurji, Cofounder and CEO of Cyclica

You may also like

More in DRUG DISCOVERY

Latest Posts

Login to your account

Reset Password

Answers

Account Activation